Target gene analysis by microarrays and chromatin immunoprecipitation identifies HEY proteins as highly redundant bHLH repressors

PLoS Genetics

Volumn 8, Issue 5, 2012, Pages

  Heisig, Julia ^a   Weber, David ^a   Englberger, Eva ^a   Winkler, Anja ^a   Kneitz, Susanne ^a   Sung, Wing Kin ^b   Wolf, Elmar ^a   Eilers, Martin ^a   Wei, Chia Lin ^b,c   Gessler, Manfred ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b GENOME INSTITUTE OF SINGAPORE   (Singapore)

^c DOE JOINT GENOME INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; HEY PROTEIN; HEY1 PROTEIN; HEY2 PROTEIN; HEYL PROTEIN; MESSENGER RNA; REPRESSOR PROTEIN; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; HEY1 PROTEIN, HUMAN; HEY2 PROTEIN, HUMAN; HEYL PROTEIN, HUMAN; NOTCH RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL STRAIN HEK293; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; E BOX ELEMENT; GENE ACTIVATION; GENE EXPRESSION; GENE IDENTIFICATION; GENE TARGETING; HEART MUSCLE CELL; HEY GENE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN FUNCTION; REGULATOR GENE; ANIMAL; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOUSE MUTANT; SIGNAL TRANSDUCTION;

MURINAE; MUS;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BINDING SITES; CELL CYCLE PROTEINS; CHROMATIN IMMUNOPRECIPITATION; DNA-BINDING PROTEINS; E-BOX ELEMENTS; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; MICE; MICE, KNOCKOUT; MYOCYTES, CARDIAC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; RECEPTORS, NOTCH; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION;

EID: 84863692070     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1002728     Document Type: Article

References (42)

1. Wiese C, Heisig J, Gessler M, (2010) Hey bHLH factors in cardiovascular development. Pediatr Cardiol 31: 363-370.
2. Fischer A, Gessler M, (2007) Delta-Notch-and then? Protein interactions and proposed modes of repression by Hes and Hey bHLH factors. Nucleic Acids Res 35: 4583-4596.
3. Fischer A, Steidl C, Wagner TU, Lang E, Jakob PM, et al. (2007) Combined loss of Hey1 and HeyL causes congenital heart defects because of impaired epithelial to mesenchymal transition. Circ Res 100: 856-863.
4. Fukada S, Yamaguchi M, Kokubo H, Ogawa R, Uezumi A, et al. (2011) Hesr1 and Hesr3 are essential to generate undifferentiated quiescent satellite cells and to maintain satellite cell numbers. Development 138: 4609-4619.
5. Fischer A, Schumacher N, Maier M, Sendtner M, Gessler M, (2004) The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev 18: 901-911.
6. Kokubo H, Miyagawa-Tomita S, Nakazawa M, Saga Y, Johnson RL, (2005) Mouse hesr1 and hesr2 genes are redundantly required to mediate Notch signaling in the developing cardiovascular system. Dev Biol 278: 301-309.
7. Doetzlhofer A, Basch ML, Ohyama T, Gessler M, Groves AK, et al. (2009) Hey2 regulation by FGF provides a Notch-independent mechanism for maintaining pillar cell fate in the organ of Corti. Dev Cell 16: 58-69.
8. Fuke S, Minami N, Kokubo H, Yoshikawa A, Yasumatsu H, et al. (2006) Hesr1 knockout mice exhibit behavioral alterations through the dopaminergic nervous system. J Neurosci Res 84: 1555-1563.
9. Salie R, Kneissel M, Vukevic M, Zamurovic N, Kramer I, et al. (2010) Ubiquitous overexpression of Hey1 transcription factor leads to osteopenia and chondrocyte hypertrophy in bone. Bone 46: 680-694.
10. Jalali A, Bassuk AG, Kan L, Israsena N, Mukhopadhyay A, et al. (2011) HeyL promotes neuronal differentiation of neural progenitor cells. J Neurosci Res 89: 299-309.
11. Chi JT, Chang HY, Haraldsen G, Jahnsen FL, Troyanskaya OG, et al. (2003) Endothelial cell diversity revealed by global expression profiling. Proc Natl Acad Sci U S A 100: 10623-10628.
12. Koibuchi N, Chin MT, (2007) CHF1/Hey2 plays a pivotal role in left ventricular maturation through suppression of ectopic atrial gene expression. Circ Res 100: 850-855.
13. Xin M, Small EM, van Rooij E, Qi X, Richardson JA, et al. (2007) Essential roles of the bHLH transcription factor Hrt2 in repression of atrial gene expression and maintenance of postnatal cardiac function. Proc Natl Acad Sci U S A 104: 7975-7980.
14. Fischer A, Klattig J, Kneitz B, Diez H, Maier M, et al. (2005) Hey basic helix-loop-helix transcription factors are repressors of GATA4 and GATA6 and restrict expression of the GATA target gene ANF in fetal hearts. Mol Cell Biol 25: 8960-8970.
15. Sultan M, Schulz MH, Richard H, Magen A, Klingenhoff A, et al. (2008) A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome. Science 321: 956-960.
16. Wong ET, Kolman JL, Li YC, Mesner LD, Hillen W, et al. (2005) Reproducible doxycycline-inducible transgene expression at specific loci generated by Cre-recombinase mediated cassette exchange. Nucleic Acids Res 33: e147.
17. Birney E, Stamatoyannopoulos JA, Dutta A, Guigo R, Gingeras TR, et al. (2007) Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447: 799-816.
18. Fischer A, Leimeister C, Winkler C, Schumacher N, Klamt B, et al. (2002) Hey bHLH factors in cardiovascular development. Cold Spring Harb Symp Quant Biol 67: 63-70.
19. Claycomb WC, Lanson NA Jr, Stallworth BS, Egeland DB, Delcarpio JB, et al. (1998) HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci U S A 95: 2979-2984.
20. Gessler M, Knobeloch KP, Helisch A, Amann K, Schumacher N, et al. (2002) Mouse gridlock: no aortic coarctation or deficiency, but fatal cardiac defects in Hey2-/- mice. Curr Biol 12: 1601-1604.
21. Kageyama R, Niwa Y, Shimojo H, Kobayashi T, Ohtsuka T, (2010) Ultradian oscillations in Notch signaling regulate dynamic biological events. Curr Top Dev Biol 92: 311-331.
22. Ho JW, Bishop E, Karchenko PV, Negre N, White KP, et al. (2011) ChIP-chip versus ChIP-seq: lessons for experimental design and data analysis. BMC Genomics 12: 134.
23. Cao Y, Yao Z, Sarkar D, Lawrence M, Sanchez GJ, et al. (2010) Genome-wide MyoD binding in skeletal muscle cells: a potential for broad cellular reprogramming. Dev Cell 18: 662-674.
24. Zeller KI, Zhao X, Lee CW, Chiu KP, Yao F, et al. (2006) Global mapping of c-Myc binding sites and target gene networks in human B cells. Proc Natl Acad Sci U S A 103: 17834-17839.
25. Perna D, Faga G, Verrecchia A, Gorski MM, Barozzi I, et al. (2011) Genome-wide mapping of Myc binding and gene regulation in serum-stimulated fibroblasts. Oncogene.
26. Iso T, Kedes L, Hamamori Y, (2003) HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol 194: 237-255.
27. Leal MC, Surace EI, Holgado MP, Ferrari CC, Tarelli R, et al. (2011) Notch signaling proteins HES-1 and Hey-1 bind to insulin degrading enzyme (IDE) proximal promoter and repress its transcription and activity: Implications for cellular Abeta metabolism. Biochim Biophys Acta.
28. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, et al. (2006) A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125: 315-326.
29. Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA, (2007) A chromatin landmark and transcription initiation at most promoters in human cells. Cell 130: 77-88.
30. Stegmeier F, Hu G, Rickles RJ, Hannon GJ, Elledge SJ, (2005) A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells. Proc Natl Acad Sci U S A 102: 13212-13217.
31. Krueger C, Danke C, Pfleiderer K, Schuh W, Jack HM, et al. (2006) A gene regulation system with four distinct expression levels. J Gene Med 8: 1037-1047.
32. Balciunas D, Wangensteen KJ, Wilber A, Bell J, Geurts A, et al. (2006) Harnessing a high cargo-capacity transposon for genetic applications in vertebrates. PLoS Genet 2: e169 doi:10.1371/journal.pgen.0020169.
33. Huber W, von Heydebreck A, Sultmann H, Poustka A, Vingron M, (2002) Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18 (Suppl 1): S96-104.
34. Wei CL, Wu Q, Vega VB, Chiu KP, Ng P, et al. (2006) A global map of p53 transcription-factor binding sites in the human genome. Cell 124: 207-219.
35. Langmead B, Trapnell C, Pop M, Salzberg SL, (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10: R25.
36. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, et al. (2008) Model-based analysis of ChIP-Seq (MACS). Genome Biol 9: R137.
37. Salmon-Divon M, Dvinge H, Tammoja K, Bertone P, (2010) PeakAnalyzer: genome-wide annotation of chromatin binding and modification loci. BMC Bioinformatics 11: 415.
38. Ye T, Krebs AR, Choukrallah MA, Keime C, Plewniak F, et al. (2011) seqMINER: an integrated ChIP-seq data interpretation platform. Nucleic Acids Res 39: e35.
39. Huang da W, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
40. Calva-Cerqueira D, Dahdaleh FS, Woodfield G, Chinnathambi S, Nagy PL, et al. (2010) Discovery of the BMPR1A promoter and germline mutations that cause juvenile polyposis. Hum Mol Genet 19: 4654-4662.
41. Lee JC, Smith SB, Watada H, Lin J, Scheel D, et al. (2001) Regulation of the pancreatic pro-endocrine gene neurogenin3. Diabetes 50: 928-936.
42. Ban J, Bennani-Baiti IM, Kauer M, Schaefer KL, Poremba C, et al. (2008) EWS-FLI1 suppresses NOTCH-activated p53 in Ewing's sarcoma. Cancer Res 68: 7100-7109.